Congruence Therapeutics

Congruence Therapeutics

Headquarter
Montreal, Quebec - Canada

Milestones
Founded: 2021
Invested: 2021

Founders / CEO
Clarissa Desjardins, CEO

Vertical
Biotech

Board Participation
Thomas Thestrup, Board Member

Website

Linkedin

 

 

 

Developer of pharmacological stabilizer designed for the treatment of rare diseases. The company uses the interface of computational and experimental drug discovery, structural bioinformatics, computational chemistry, and machine learning to deploy an in silico platform that enables the design of a validated class of small molecules, enabling researchers to design novel small molecules for diseases of protein misfolding.